TRVI
TRVI

Trevi Therapeutics Inc

NASDAQ · Pharmaceuticals
$11.46
+0.52 (+4.75%)
Analyst Consensus
Strong Buy
18 analysts
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +91.4% upside
Low Target $18.04
Average Target $21.93
High Target $33.12
Current Price $11.46
Current
$11.46
Target
$21.93
$18.04 $21.93 avg $33.12